Alisa Bank Plc – Managers’ Transactions – WRCC Invest Oy
Reading Time: < 1 minute ALISA BANK PLC MANAGER TRANSACTIONS 19.11.2024 AT 10.20 EET Person subject to the notification requirementName: WRCC Invest Oy Position: Member of the Board/Deputy member(X) Legal person (1): Person Discharging Managerial Responsibilities In IssuerName: Tero WeckrothPosition: Member of the Board Issuer: Alisa
TA Announces Strategic Investment in Vee Healthtek to Support Continued Growth and Innovation
Reading Time: 3 minutes Boston, New York, United States & Bengaluru, Karnataka, India: TA Associates (“TA”), a leading global private equity firm, today announced the completion of a strategic growth investment in Vee Healthtek (“the Company”), a prominent provider of technology-enabled solutions and services for
Lava AGNI 3 Spurs 200% Growth, Achieves 3x Volume Surge Over AGNI 2 During Launch Week
Reading Time: 2 minutes Lava International Limited, the leading Indian smartphone manufacturer, announced the outstanding success of their flagship AGNI 3, clocking a 200% growth during launch week and a threefold increase in volume compared to its predecessor, AGNI 2. This milestone highlights Lava’s commitment to innovation, quality, and
FARO BIDCO APS HAS COMPLETED THE UNREGULATED RECOMMENDED VOLUNTARY OFFER TO THE SHAREHOLDERS OF EVERFUEL A/S
Reading Time: 5 minutes NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, INTO OR WITHIN CANADA, AUSTRALIA, NEW ZEALAND, SOUTH-AFRICA, HONG KONG, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS
Uniqus Consultech Onboards UST as an Investor, as Part of its Previously Announced Series B Round
Reading Time: 3 minutes Aliso Viejo, Calif., United States & Mumbai, Maharashtra, India: UST, a leading digital transformation solutions company, has invested in Uniqus Consultech, a tech-enabled global platform that offers consulting solutions in the accounting & reporting, finance operations, governance, risk, ESG, and technology
Invest in Bogota Seeks New Investment Opportunities at Bengaluru Tech Summit 2024
Reading Time: 2 minutes From November 19 to 21, Invest in Bogota, the investment promotion agency of Colombia’s capital, will participate in the Bengaluru Tech Summit 2024, one of the world’s leading events for the global tech ecosystem. This year’s summit will feature over 400 speakers, including
Synsam Group’s Q3 report 2024
Reading Time: 5 minutes Continued organic growth by consistent strategy execution 1 July – 30 September 2024 Net sales increased to SEK 1,559 million (1,450), up 7.6 percent. Organic growth totalled 9.5 percent (7.0) Net sales from spectacles subscriptions increased 11.0 percent (13.7) The gross
Guidewire Outlines Vision for How Modern Core Platforms will Unlock a New Era of Efficiency and Effectiveness in P&C Insurance
Reading Time: 6 minutes Nashville, Tenn., United States: CONNECTIONS CONFERENCE – Guidewire (NYSE: GWRE) will showcase its commitment to improving risk selection and pricing, indemnity management, and claims efficiency in property and casualty insurance at its annual customer conference, Connections. The event will unveil future
Lytix Biopharma Q3 2024: Positive clinical results and strategic advancements strengthen path to commercialization
Reading Time: 3 minutes Oslo, 19 November 2024. Lytix Biopharma (“Lytix”) (Euronext Growth Oslo: LYTIX), a Norwegian immuno-oncology company dedicated to being part of tomorrow’s cancer treatment, today releases its third quarter 2024 results. Lytix achieved substantial progress in its clinical pipeline, progressing towards
Novotech Releases Comprehensive Report on the Global Clinical Trial Landscape for Small Cell Lung Cancer (SCLC)
Reading Time: 2 minutes San Francisco, United States: Novotech, the global full-service clinical Contract Research Organization (CRO), has published a new report, Small Cell Lung Cancer: Global Clinical Trial Landscape 2024, providing an in-depth analysis of current trends, challenges, and opportunities in SCLC clinical trials